Chaney Capital Management’s Amgen AMGN Stock Holding History

Chaney Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$298K	Hold	846	–	–	0.1%	33
2025 Q4	$277K	Buy	846 +75	+10%	+$23.8K	0.1%	34
2025 Q3	$218K	Buy	+771	New	+$224K	0.08%	36

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Chaney Capital Management's AMGN Position: Q1 2026 in Review

Chaney Capital Management held its Amgen (AMGN) position steady in Q1 2026 at 846 shares worth $298K. The position accounts for 0.1% of the portfolio, ranked #33.

Chaney Capital Management first reported a position in AMGN in Q3 2025 and has held it in 3 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Chaney Capital Management held 846 shares of Amgen worth $298K as of Q1 2026.
Chaney Capital Management left its Amgen share count unchanged in Q1 2026.
Amgen made up 0.1% of Chaney Capital Management's portfolio in Q1 2026, its #33 holding.
Chaney Capital Management first reported a position in Amgen in Q3 2025 and has held it in 3 quarters since.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Chaney Capital Management's 13F filing for Q1 2026, filed 11 May 2026.